Translational Science

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

When art and science meet, true inspiration can be found and tapped into.

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.

How do we battle gut bacteria that reduce medicine efficacy?

The game “Tumor Quest” seeks to improve people’s understanding of cancer.

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.

Why are spherical nucleic acids so exciting for drug development?